(Q36782571)

16 August 2017

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment (English)

1 reference

16 August 2017

1 reference

1 reference

McKenna WJ

1

1 reference

16 August 2017

Harris L

2

1 reference

16 August 2017

Perez G

3

1 reference

16 August 2017

Krikler DM

4

1 reference

16 August 2017

Oakley C

5

1 reference

16 August 2017

Goodwin JF

6

1 reference

16 August 2017

language of work or name

1 reference

1 August 1981

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

46

1 reference

16 August 2017

2

1 reference

16 August 2017

173-178

1 reference

Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Prognosis and mortality of hypertrophic obstructive cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Treatment of hypertrophic obstructive cardiomyopathy with verapamil

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

“Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Impaired Rate of Left Ventricular Filling in Idiopathic Hypertrophic Subaortic Stenosis and Valvular Aortic Stenosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Comparison of Ventricular Ectopic Activity during 24-Hour Monitoring and Exercise Testing in Patients with Coronary Heart Disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482624

Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy

27 June 2018

1 reference

12 December 2020

M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction

1 reference

12 December 2020

IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS

1 reference

12 December 2020

Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.46.2.173

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

7196769

1 reference